Evidence map›Paper›PMID 18535150›Full record

ReviewMicrobiology and molecular biology reviews : MMBR2008

EcoR124I: from plasmid-encoded restriction-modification system to nanodevice.

James Youell, Keith Firman

Abstract readReview
In one paragraph

Review in Microbiology and molecular biology reviews : MMBR, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Characterization of theFrontiers in microbiology · 2023
    Article
  2. Expression and Purification ofFrontiers in microbiology · 2022
    Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

James YouellSchool of Biological Sciences, King Henry Building, University of Portsmouth, King Henry I Street, Portsmouth, Hants PO1 2DY, United Kingdom.
Keith Firman

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

summaryPlasmid R124 was first described in 1972 as being a new member of incompatibility group IncFIV, yet early physical investigations of plasmid DNA showed that this type of classification was more complex than first imagined. Throughout the history of the study of this plasmid, there have been many unexpected observations. Therefore, in this review, we describe the history of our understanding of this plasmid and the type I restriction-modification (R-M) system that it encodes, which will allow an opportunity to correct errors, or misunderstandings, that have arisen in the literature. We also describe the characterization of the R-M enzyme EcoR124I and describe the unusual properties of both type I R-M enzymes and EcoR124I in particular. As we approached the 21st century, we began to see the potential of the EcoR124I R-M enzyme as a useful molecular motor, and this leads to a description of recent work that has shown that the R-M enzyme can be used as a nanoactuator. Therefore, this is a history that takes us from a plasmid isolated from (presumably) an infected source to the potential use of the plasmid-encoded R-M enzyme in bionanotechnology.

Indexed as

Deoxyribonucleases, Type I Site-SpecificDNA, BacterialDNA Restriction-Modification EnzymesModels, MolecularMolecular Sequence DataNanostructuresPlasmidsSite-Specific DNA-Methyltransferase (Adenine-Specific)Deoxyribonucleases, Type I Site-SpecificDNA, BacterialDNA Restriction-Modification EnzymesSite-Specific DNA-Methyltransferase (Adenine-Specific)

Identifiers

PMID18535150
PMCPMC2415743

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.